04.17.2023 Kabuki Syndrome Team Selected to Join Aspire Biosciences’ Partnering Event Kabuki Syndrome Team Selected to Join Treatment-Focused Networking Event NEW YORK, April 17, 2023— After submitting...
04.10.2023 KSF is Growing! New Research Team: Drs. Bloom and Tang Kabuki Syndrome Foundation Appoints Dr. Bruce Bloom and Dr. Clara Tang to Lead Treatment-Focused Research...
11.30.2022 KSF Survey Leads to Planned Expansion of Dietary Clinical Trial In the summer of 2022, the Kabuki Syndrome Foundation hosted its annual crowdsourcing survey. This...
06.14.2022 Kabuki Syndrome Foundation Awards $125,000 to Fund Research at Kennedy Krieger Institute BALTIMORE, June 14, 2022—Dr. Jacqueline Harris, a pediatric neurologist and director of Kennedy Krieger’s Epigenetics...
05.03.2022 ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, May 3rd, 2022 – Oryzon Genomics, S.A. (ISIN Code:...
09.27.2021 AllStripes + KSF Partnership is formed The more we know about Kabuki syndrome, the more we can do for Kabuki syndrome...